SCRI has many ongoing clinical trials. Participation in a clinical trial is the first step in fighting cancer, not the last.®
SCRI uses a network model, with more than 700 community-based oncologists across 25 states and the United Kingdom, making our trials easily accessible to a broad patient base.
Personalized medicine takes an integrated, coordinated, evidence-based approach to individualizing patient care across the continuum from health to disease.
NewsSee All News >>
May 9 The Association of Cancer Physicians (ACP) is bringing you the latest oncology data from 2013 ASCO® Annual Meeting via a series of online webcasts with a team of the UK’s leading oncologists.
May 3 HCA redefined community-based hospital care, and now it hopes to redefine world-class cancer care through its wholly owned subsidiary, Sarah Cannon.
Apr 29 A new genetic profiling laboratory that will pioneer a quick and cost-effective new tumour test will give doctors a better chance of identifying the right treatment for UK cancer patients and increase access to clinical trials for the latest therapies.
Apr 5 Sarah Cannon Research Institute (SCRI) principal investigators authored fourteen abstracts accepted for presentation at the American Association for Cancer Research Annual Meeting 2013, which runs from April 6-10 in Washington, D.C.
Sarah Cannon Research Institute has a library of videos that provide information about various treatments, diseases, as well as understanding the phases of clinical trials. View our video library to learn more.